Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic analysis of cuproptosis subtypes and immunological features in severe influenza. | Microb Pathog | 2023 | 37207785 | PubTator, text mining | PubMed |
| T cell-mediated tumor killing patterns in head and neck squamous cell carcinoma identify novel molecular subtypes, with prognosis and therapeutic implications. | PLoS One | 2023 | 37192179 | PubTator, text mining | PubMed |
| Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma. | Eur J Med Res | 2023 | 37189176 | PubTator, text mining | PubMed |
| ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer. | BMC Cancer | 2023 | 37189064 | PubTator, text mining | PubMed |
| Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy. | Nat Commun | 2023 | 37188663 | PubTator, text mining | PubMed |
| Development of a high-resolution mass-spectrometry-based method and software for human leukocyte antigen typing. | Front Immunol | 2023 | 37187759 | PubTator, text mining | PubMed |
| Association of asthma genetic variants with asthma-associated traits reveals molecular pathways of eosinophilic asthma. | Clin Transl Allergy | 2023 | 37186423 | PubTator, text mining | PubMed |
| Survival and debonding resistance of posterior cantilever resin-bonded fixed dental prostheses for moderately and severely worn dentition during thermomechanical loading. | Dent Mater | 2023 | 37183157 | PubTator, text mining | PubMed |
| Prediction of HLA genotypes from single-cell transcriptome data. | Front Immunol | 2023 | 37180102 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8+ and CD4+ T Cell Responses Restricted to Each HLA Class I and II Allotype Within an Individual. | Immune Netw | 2023 | 37179751 | PubTator, text mining | PubMed |
| Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. | Breast Cancer | 2023 | 37178414 | PubTator, text mining | PubMed |
| Harnessing immunoinformatics for developing a multiple-epitope peptide-based vaccination approach against SARS-CoV-2 spike protein. | Saudi J Biol Sci | 2023 | 37163156 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis. | medRxiv | 2023 | 37163015 | PubTator, text mining | PubMed |
| Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data. | BMC Genomics | 2023 | 37161318 | PubTator, text mining | PubMed |
| RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma. | Sci Rep | 2023 | 37161020 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity. | Cell Rep | 2023 | 37155329 | PubTator, text mining | PubMed |
| Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing. | Front Genet | 2023 | 37152992 | PubTator, text mining | PubMed |
| High Expression of Tumor HLA-DR Predicts Better Prognosis and Response to Anti-PD-1 Therapy in Laryngeal Squamous Cell Carcinoma. | Transl Oncol | 2023 | 37149969 | PubTator, text mining | PubMed |
| Association of HLA diversity with the risk of 25 cancers in the UK Biobank. | EBioMedicine | 2023 | 37148584 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=21